Long-Term Clinical Outcomes With Zotarolimus-Eluting Versus Bare-Metal Coronary Stents-Reference-Cited by-同舟云学术

Long-Term Clinical Outcomes With Zotarolimus-Eluting Versus Bare-Metal Coronary Stents

Published:2010-12 Issue:12 Volume:3 Page:1240-1249
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Mauri Laura,Massaro Joseph M.,Jiang Songtao,Meredith Ian,Wijns William,Fajadet Jean,Kandzari David E.,Leon Martin B.,Cutlip Donald E.,Thompson Kweli P.

Funder

Medtronic

Cordis

Abbott Vascular

Boston Scientific

Eli Lilly

Daiichi-Sankyo

Bristol-Myers Squibb

sanofi aventis

Cordis Corporation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. Percutaneous coronary intervention in the current era compared with 1985–1986: the National Heart, Lung, and Blood Institute registries;Williams;Circulation,2000

2. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial;Fajadet;Circulation,2006

3. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

4. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease;Stone;N Engl J Med,2004

5. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial;Stone;JAMA,2008

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and Advances in Interventional Cardiology for Coronary Artery Disease Management;Medicina;2024-08-15

2. Advancements in Percutaneous Coronary Intervention Techniques: A Comprehensive Literature Review of Mixed Studies and Practice Guidelines;Cureus;2023-07-03

3. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis;BMC Cardiovascular Disorders;2021-09-17

4. Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy;APL Bioengineering;2021-06-01

5. Treatment of coronary in-stent restenosis: a systematic review;J GERIATR CARDIOL;2018